These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Halupa A, Bailey ML, Huang K, Iscove NN, Levy DE, Barber DL. Blood; 2005 Jan 15; 105(2):552-61. PubMed ID: 15213094 [Abstract] [Full Text] [Related]
4. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O. Blood; 1998 May 15; 91(10):3734-45. PubMed ID: 9573010 [Abstract] [Full Text] [Related]
5. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Bouscary D, Pene F, Claessens YE, Muller O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C. Blood; 2003 May 01; 101(9):3436-43. PubMed ID: 12506011 [Abstract] [Full Text] [Related]
6. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Yamamura Y, Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y. Mol Cell Biol; 1998 Mar 01; 18(3):1172-80. PubMed ID: 9488432 [Abstract] [Full Text] [Related]
7. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. Akagi S, Ichikawa H, Okada T, Sarai A, Sugimoto T, Morimoto H, Kihara T, Yano A, Nakao K, Nagake Y, Wada J, Makino H. J Am Soc Nephrol; 2004 Dec 01; 15(12):3215-24. PubMed ID: 15579525 [Abstract] [Full Text] [Related]
8. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3. Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O. Blood; 1997 Jun 15; 89(12):4327-36. PubMed ID: 9192755 [Abstract] [Full Text] [Related]
9. Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors. Ghaffari S, Kitidis C, Fleming MD, Neubauer H, Pfeffer K, Lodish HF. Blood; 2001 Nov 15; 98(10):2948-57. PubMed ID: 11698276 [Abstract] [Full Text] [Related]
10. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia. Zochodne B, Truong AH, Stetler K, Higgins RR, Howard J, Dumont D, Berger SA, Ben-David Y. Oncogene; 2000 May 04; 19(19):2296-304. PubMed ID: 10822380 [Abstract] [Full Text] [Related]
11. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells. Sakamoto H, Kitamura T, Yoshimura A. J Biol Chem; 2000 Nov 17; 275(46):35857-62. PubMed ID: 10960479 [Abstract] [Full Text] [Related]
12. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Arcasoy MO, Harris KW, Forget BG. Exp Hematol; 1999 Jan 17; 27(1):63-74. PubMed ID: 9923445 [Abstract] [Full Text] [Related]
13. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A. J Biol Chem; 2000 Sep 22; 275(38):29338-47. PubMed ID: 10882725 [Abstract] [Full Text] [Related]
14. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Sathyanarayana P, Dev A, Pradeep A, Ufkin M, Licht JD, Wojchowski DM. Blood; 2012 Jun 07; 119(23):5522-31. PubMed ID: 22508938 [Abstract] [Full Text] [Related]
16. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J. Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791 [Abstract] [Full Text] [Related]
17. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms. Miller CP, Heilman DW, Wojchowski DM. Blood; 2002 Feb 01; 99(3):898-904. PubMed ID: 11806992 [Abstract] [Full Text] [Related]
18. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways. Shi J, Yuan B, Hu W, Lodish H. Exp Hematol; 2016 Nov 01; 44(11):1044-1058.e5. PubMed ID: 27473563 [Abstract] [Full Text] [Related]
19. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Erickson-Miller CL, Pelus LM, Lord KA. Stem Cells; 2000 Nov 01; 18(5):366-73. PubMed ID: 11007921 [Abstract] [Full Text] [Related]
20. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction. Sawyer ST, Penta K. J Biol Chem; 1996 Dec 13; 271(50):32430-7. PubMed ID: 8943308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]